Parental Methamphetamine Use and Manufacture: Child and Familial Outcomes

Nena Messina1, Kira Jeter

  • 1Integrated Substance Abuse Programs (ISAP) Semel Institute for Neuroscience and Human Behavior Department of Psychiatry and Biobehavioral Sciences David Geffen School of Medicine University of California, Los Angeles nmessina@ucla.edu 310.267.5509.

Journal of Public Child Welfare
|August 11, 2012
PubMed

Insights

Children exposed to methamphetamine (MA) manufacturing face severe neglect and harm. This study details the outcomes for children removed from MA lab environments, highlighting significant child protective services involvement and medical issues.

Area of Science:

  • Child Health
  • Toxicology
  • Criminology

Background:

  • Children of methamphetamine (MA) users and manufacturers face high risks of neglect, abuse, and physical harm.
  • Exposure to illicit drug manufacturing environments poses significant dangers to child well-being.

Purpose of the Study:

  • To document the epidemiology of children removed from home-based MA labs.
  • To analyze the familial outcomes for these drug-endangered children.

Main Methods:

  • Descriptive analysis of 99 cases of drug-endangered children.
  • Data collected from children removed from home-based MA labs in Los Angeles County (2001-2003).

Main Results:

  • Substantiated neglect was confirmed in 93% of cases.
  • Child protective services detainment occurred in 97% of cases.
  • Eighty percent of children had documented medical diagnoses, often linked to MA manufacturing exposure.

Conclusions:

  • Children removed from MA labs experience high rates of neglect and require significant child protective services intervention.
  • Exposure to MA manufacturing environments is associated with substantial medical problems in children.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...